A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium

BACKGROUND: Currently, nanoliposomal irinotecan (nal-IRI) + 5-fluorouracil/folinic acid (5-FU/LV) is the only approved second-line treatment for patients suffering from metastatic pancreatic ductal adenocarcinoma (mPDAC). However, also other chemotherapeutic regimens are used in this setting and due...

Descripción completa

Detalles Bibliográficos
Autores principales: Verbruggen, Lise, Verheggen, Lisa, Vanhoutte, Greetje, Loly, Catherine, Lybaert, Willem, Borbath, Ivan, Vergauwe, Philippe, Hendrickx, Koen, Debeuckelaere, Celine, de Haar-Holleman, Amy, Van Laethem, Jean-Luc, Peeters, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439761/
https://www.ncbi.nlm.nih.gov/pubmed/37600936
http://dx.doi.org/10.1177/17588359231181500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439761/
https://www.ncbi.nlm.nih.gov/pubmed/37600936
http://dx.doi.org/10.1177/17588359231181500

Ejemplares similares